CUA Educational Content

CUA Highlights of SNMMI 2024

Speakers: Patrick Martineau & Katherine Zukotynski

Objectives:

By participating in this learning program, healthcare providers can expect to:

  • Review key updates from SNMMI 2024 related to PSMA PET and PSMA-targeted RLT in prostate cancer
  • Discuss novel approaches to RLT currently being investigated in the area of prostate cancer
  • Examine the implications of new data for the management of patients with prostate cancer in Canadian clinical practice
Start Quiz for Credits

SECTION 3 ACCREDITATION

This activity is an Accredited Self-Assessment Program (Section 3) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada, and approved by CUA. You may claim a maximum of 1 hour of credit.

This program has received financial support from Novartis in the form of an educational grant.

The Canadian Urological Association (CUA) does not provide professional medical advice, diagnosis or treatment and cannot respond to requests for direct feedback, specific patient information or physician referrals. You should first always seek the advice of your urologist, physician and other qualified health provider with any questions regarding your medical condition. The contents of the CUA Website such as text, graphics, images, and other content are for informational purposes only. The content/information is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Never disregard professional medical advice or delay in seeking it because of something you have read on the CUA website.

For comments or information, email Corporate.office@cua.org

Privacy Policy